TG Therapeutics (TGTX) AGM 2026 summary

Opening remarks and agenda

• The meeting was formally called to order and directors, auditors, and legal counsel were introduced.

• The agenda included voting on three items as described in the proxy statement.

Board and executive committee updates

• Directors nominated for election included Laurence N. Charney, Yann Echelard, Kenneth Hoberman, Daniel Hume, Dr. Sagar Lonial, and Michael S. Weiss, to serve until the 2027 annual meeting or until successors are elected.

Shareholder proposals

• Three items were presented for shareholder voting: election of directors, ratification of KPMG LLP as auditors for 2026, and an advisory vote on executive compensation.